Associated Papers
Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case report.
Xiang S et al.
Heliyon, 2023
Select a paper to view details